Subscribe Now Subscribe Today
Fulltext PDF
Research Article

Biodisposition Kinetics of Ofloxacin in Pakistani Healthy Female Volunteers after Oral Administration

Amjad Hameed , Faiz Batool , Tahira Iqbal , Tayyba Tabassum Baig and Javed Anver Qureshi

This study was based on biodisposition kinetics of ofloxacin in Pakistani healthy female volunteers after oral administration. Ten healthy female volunteers were included in this study. The blood samples of each volunteer were collected after oral administration of ofloxacin. The concentration of ofloxacin in blood samples was measured by microbiological assay. The mean (SE) values of time to peak (tmax), peak concentration (Cmax), absorption half life (t1/2α), absorption rate constant (ka), elimination half life (t1/2), elimination rate constant (K10β), were 1.012 ± 0.176 h, 0.907 ± 0.126 μg ml-1, 0.516? 0.093h, 13.593?2.936L h-1, 2.996 ± 0.567h and 0.291 ± 0.693 L h-1 respectively. The mean (SE) values for area under curve (AUC), clearance (CL), volume of distribution (Vd) and mean resident time (MRT) were 4.358 ± 0.771 1itter, 53.470 ± 11.068 l h-1, 214.41?49.127 litter and 5.030 ± 0.705 h respectively. Values of parameters like, volume of distribution, total body clearance and absorption rate constant were higher, while elimination half life, AUC, Cmax, and tmax were lower in local population as compared with foreign studies. There was no influence of body surface area on total body clearance of ofloxacin (R2=0.0581). There was an increase in body clearance of ofloxacin (R2=0.2236) and area under curve (AUC) for ofloxacin (R2=0.258) with increasing body surface are of volunteers. Therefore body surface area of volunteers may slightly influence the total body clearance and area under curve for ofloxacin. These gender-related differences mainly low body weight and surface area in females may warrant dosage adjustments.

Related Articles in ASCI
Similar Articles in this Journal
Search in Google Scholar
View Citation
Report Citation

  How to cite this article:

Amjad Hameed , Faiz Batool , Tahira Iqbal , Tayyba Tabassum Baig and Javed Anver Qureshi , 2002. Biodisposition Kinetics of Ofloxacin in Pakistani Healthy Female Volunteers after Oral Administration. Journal of Biological Sciences, 2: 775-779.

DOI: 10.3923/jbs.2002.775.779


Arret, B., D.P. Johnson and A. Krishbaum, 1971. Out line of detail for microbiological assay of antibiotics. J. Pharm. Sci., 60: 373-378.

Baggot, J.D., 1977. Principles of Drug Disposition in Domestic Animals. W.B. Saunders Company, Philadelphia, London, Toronto, pp: 117-118.

Corvaisier, S., N. Bleyzac, M. DeMontclos, M. Druguet, G. Aldrand, G. Carret and P. Maire, 1999. Renal fedifrential aging processes and ofloxacin pharmacokinetics in the elderly. Therapeutics, 54: 223-231.
PubMed  |  

Eboka, C.J., R.S. Okor, J.O. Akerele and S.O. Aigbavboa, 1997. Kinetics of absorption and elimination of ofloxacin in humans after oral and retail administration. J. Clin. Pharmcol. Therapeutics., 23: 217-220.

Echols, R., M.P. Weinstein, B. Okeefe, A. Shah and A.H. Heller, 1994. Comparative crossover assessment of serum bactericidal activity and pharmacokinetics of pefloxacin and ofloxacin in healthy volunteers. Drugs Exp. Clin. Res., 18: 487-492.

Flor, S., D. Guay, J. Opsahl, K. Track and G. Matzke, 1991. Pharmacokinetics of ofloxacin in healthy subjects and patients with varying degrees of renal impairment. Int. J. Clin. Pharmacol. Res., 11: 115-121.

Ganong, F.W., 1995. Review of Medical Physiology. 7th Edn., University of California San Francise, California, pp: 258.

Gillman, A.G., L.S. Goodman, T.W. Rall and R. Marad, 1985. The Pharmacological Basis of Therapeutic. McMillan Publishing Co., New York, pp: 1- 2.

Guay, D., K. Track and S. Flor, 1991. Safety and Pharmacokinetics of single dose intravenous ofloxacin in healthy volunteers. Int. J. Clin. Parmacol. Res., 11: 203-209.
PubMed  |  Direct Link  |  

Guay, D.R., J.A. Opsahl, F.G. Mcmahom, R. Vargas, G.R. Matzke and S. Flor, 1992. Safety and pharmacokinetics of multiple doses of intravenous ofloxacin in healthy volunteers. Antimicrobial Agents Chemother., 36: 308-312.
Direct Link  |  

Hameed, A., I. Tahira, N. Muhammad, B. Faiz, B. Tayyba Tabassum, A. Shafaqat and N. Farwa, 2002. Pharmacokinetics of ofloxacin in male volunteers following oral administration. Pak. J. Biol. Sci., 5: 1098-1100.
CrossRef  |  Direct Link  |  

Israel, D., J.G. Gillum, M. Turik, K. Harvey and J. Ford et al., 1993. Pharmacokinetics and serum bactericidal titers of ciprofloxacin and ofloxacin following multiple oral doses in healthy volunteers. Antimicrobial Agents Chemother., 37: 2193-2199.

Katzung, B.G., 1998. Basic and Clinical Pharmacology. Stamford, Connecticut, America, pp: 765-768.

LaCreta, F.P., G.D. Kollia, G. Duncan, D. Behr and D.M. Grasela, 2000. Age and gender effects on the pharmacokinetics of gatifloxacin. Pharmacotherapy, 20: 67S-75S.
Direct Link  |  

Lamp, K.C., E.M. Bailey and M.J. Ryback, 1992. Ofloxacin clinical pharmacokinetics. Clin. Pharmacokinetics., 22: 32-46.
PubMed  |  

Molinaro, M., P. Villani, M.B. Regazzi, R. Roundanelli and G. Doveri, 1992. Pharmacokinetics of ofloxacin in elderly patients and in healthy young subjects. Eur. J. Clin. Pharmacol., 43: 105-107.
CrossRef  |  Direct Link  |  

Nawaz, M. and B.H. Shah, 1985. Geonetical consideration in quality assurance of pharmaceutical. Proceedings of the International on Policies Management and Quality Assurance of Pharmaceutical, April 21-25, WHO and Ministry of Health, Government of Pakistan.

Nawaz, M., 1994. Geonetical factors affecting biodisposition of drugs. Can. J. Physiol. Pharmacol. Abst., 257: 12-12.

Nawaz, M., T. Iqbal and R. Nawaz, 1988. Consideration in disposition kinetics evaluation of chemotherapeutic agent. Vet. Pharmacol. Toxicol. Therapy Food Producing Anim., 2: 57-57.

Nawaz, M., T. Iqbal and R. Nawaz, 1992. Oral disposition kinetics of ofloxacin in patients with compensated liver cirrhosis. Chemotherapy, 38: 1-6.
PubMed  |  

Rombout, F., 1987. Incorporation with university centre for pharmacy. Department of Pharmacology and Therapeutics, University of Gronigen and Medilware, Copy Right, 1987-1991.

Sowinski, K.M., S.R. Abel, W.R. Clark and B.A. Mueller, 1999. Effect of gender on the pharmacokinetics of ofloxacin. Pharmacotherapy, 19: 442-446.
PubMed  |  Direct Link  |  

Stein, G.E., M.L. Bel, S.C. Flor and M. Zinny, 1991. Bioavailability and pharmacokinetics of oral oflaxacin formulations in normal subjects. Curr. Med. Res. Opin., 12: 479-484.
Direct Link  |  

Verho, M., V. Malerezyk, D. Damm and K.H. Lehr, 1996. Pharmacokinetics of levofloxacin in comparison to the racemic mixture of ofloxacin in man. Drug Metab. Drug Interact., 13: 57-67.
Direct Link  |  

Yuen, G.J., G.L. Drusano, J. Brooks and S. Flor, 1992. Use of nonlinear, mixed-effects modeling for population analysis of ofloxacin: Effect of age on oral drug pharmacokinetics. Pharmacotherapy, 12: 88-92.
PubMed  |  Direct Link  |  

Yuk, J.H., C.H. Nightingale, R. Quintiliani and K.R. Sweeney, 1991. Bio-availability and pharmacokinetics of ofloxacin in healthy volunteers. Antimicrob. Agents Chemother., 35: 384-386.
Direct Link  |  

©  2019 Science Alert. All Rights Reserved
Fulltext PDF References Abstract